Clinical Trials Directory

Trials / Completed

CompletedNCT01111357

Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis

Study of HLA Polymorphisms in French West-Indian Patients With Rheumatoid Arthritis : A Case Control Study

Status
Completed
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
University Hospital Center of Martinique · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Rheumatoid arthritis (RA), affects between 0.3% and 1.0% of the population, it can lead to progressive joint destruction and severe disability. To date, two RA genetic susceptibility factors have been identified: HLA-DRB1-SE (Shared epitope) and PTPN22 620W alleles. The predictive value of the alleles for diagnosis of RA was previously investigated in cohorts of caucasians patients with early unclassified arthritis that showed restrained association between RA and HLA-SE. Despite the contribution of HLA to the overall genetic risk has been estimated to range from 30% to 50%, it has never been studied in the French west-Indian population.

Conditions

Interventions

TypeNameDescription
BIOLOGICALCollect of 10 ml of peripheric blood for DNA extractionAfter signed written consent, all patients have a clinic exam in order to assess the presence of eligibility criteria (Patient with Rheumatoid Arthritis that fulfil the ACR criteria of diagnosis)

Timeline

Start date
2010-02-01
Primary completion
2010-08-01
Completion
2010-08-01
First posted
2010-04-27
Last updated
2010-12-21

Locations

1 site across 1 country: Martinique

Source: ClinicalTrials.gov record NCT01111357. Inclusion in this directory is not an endorsement.